 6 months
of a TIA or stroke. The study showed a statistically significant lower rate of vascular events in patients who
received the combination regimen.132
In the Prevention Regimen for Effectively Avoiding Second Strokes trial, patients received either clopidogrel or
aspirin Ã¾ extended release dipyridamole. This trial
showed no difference in the rate of recurrent strokes,
but there was a lower incidence of major hemorrhagic
events in the clo